HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colgate Launches Optic White Toothpaste To Compete With Whitening Strips

This article was originally published in The Rose Sheet

Executive Summary

Colgate-Palmolive is rolling out Colgate Optic White toothpaste with hydrogen peroxide, an ingredient commonly formulated into tooth whitening strips.

You may also be interested in...



Colgate Offers 'Anti-Aging' Toothpaste In China, Ready For 'Prolonged' Coronavirus

Colgate expects a ‘modest negative impact’ from the coronavirus on its first quarter results, but it made contingency plans for longer-term impact. In a presentation at the CAGNY conference, CEO Noel Wallace discussed a new anti-aging toothpaste in China and the latest iteration of Colgate Optic White in the US.

Colgate Expects ‘Premiumization’ Of Oral Care To Boost North America Sales

Colgate says ‘premiumization’ of its oral care products in North America should drive improved product mix and pricing; higher-end offerings will include a recyclable Tom’s of Maine toothpaste tube and a Colgate Optic White offering. North American Q3 sales grew 1.2% to $869m.

Colgate Sensitivity, Whitening Pastes Lead “Robust” Q1 Pipeline

Colgate-Palmolive will launch Colgate Total Zx Pro-Shield Plus Sensitivity toothpaste and Colgate Optic White Dual Action toothpaste in the U.S. in the first quarter, the firm announced in a Jan. 31 earnings call. Colgate’s net sales in North America rose 3.4% in fiscal 2012 to $3.1 billion.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017682

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel